Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Case Rep Otolaryngol ; 2016: 8135967, 2016.
Article in English | MEDLINE | ID: mdl-27699075

ABSTRACT

We present an extremely rare case of a pleomorphic rhabdomyosarcoma of the true vocal fold. The histopathological diagnosis was confirmed by immunohistochemistry. The patient was treated with radical surgery including total laryngectomy and radical neck dissection followed by postoperative radiotherapy. The clinicopathologic features of this rare malignancy are discussed together with a review of the literature. This case report and literature review highlights the more favorable prognosis of pleomorphic rhabdomyosarcoma in the larynx than in other locations.

2.
Support Care Cancer ; 21(4): 1071-5, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23064902

ABSTRACT

INTRODUCTION: Glutamine is a neutral amino acid that is used by rapidly dividing cells such as erythrocytes, lymphocytes, and fibroblasts. It is also the substrate of glutathione synthesis. In normal metabolic rates, glutamine is an amino acid synthesized endogenously, but in high metabolic conditions such as cancer, it must be taken exogenously. Animal studies strongly demonstrate that glutamine protects both the upper and lower gastrointestinal tract mucosa from the effects of chemotherapy, radiotherapy, or other causes of injury. In this study, we investigated the protective effect of glutamine on radiation-induced diarrhea. PATIENTS AND METHOD: The patients were divided into glutamine-treated and placebo groups. In the glutamine-treated group, 15 g of oral glutamine was administered three times daily. The patients were evaluated for diarrhea grade according to the National Cancer Institute Common Toxicity Criteria version 3.0, (Table 1), need for loperamide use, need for supportive parenteral therapy, and treatment breaks due to diarrhea. RESULTS: There was no difference in overall diarrhea incidence when the two groups were compared. When diarrhea grade was evaluated, none of the patients in the glutamine-treated group had grade 3-4 diarrhea, but in the placebo group, grade 3-4 diarrhea was seen in 69 % of the patients. In the placebo-treated group, patients requiring loperamide and parenteral supportive therapy were 39 and 92 %, respectively. There was no treatment break in glutamine-treated patients. CONCLUSION: Glutamine may have protective effect on radiation-induced severe diarrhea.


Subject(s)
Antidiarrheals/therapeutic use , Diarrhea/drug therapy , Glutamine/therapeutic use , Neoplasms/radiotherapy , Aged , Diarrhea/etiology , Female , Humans , Male , Middle Aged , Turkey
3.
Asian Pac J Cancer Prev ; 13(8): 4101-5, 2012.
Article in English | MEDLINE | ID: mdl-23098524

ABSTRACT

PURPOSE: The degree of radiation injury to kidneys which are located within the limits of radiotherapy area is determined by the volume and the dose of radiation to which the organ is exposed. When the tolerance dose of the kidney is exceeded after a latent period of 6 months acute nephritis develops and after 18 months chronic nephritis ensues. Melatonin is known to prevent the oxidative injury of toxins and radiotherapy with its free radical scavenging capacity. METHODS AND MATERIALS: In this study 8 weeks old 24 Sprague -Dawley rats were allocated into 4 groups: Control group; Radiotherapy group (20 Gy bilaterally in 5 fractions); Melatonin group (10 mg/kg intraperitoneally), and Melatonin+radiotherapy group (20 Gy Radiotherapy in 5 fractions+ melatonin 10 mg/kg intraperitoneally). After a follow-up period of 6 months BUN was determined in all groups. After rats were euthanized the kidneys were removed for histopathological examination under both light and electron microscopes. RESULTS: After 6 months follow-up, both at light and electron microscopy levels, the rats in radiotherapy+melatonin group were significantly protected against the radiation injury comparing to radiotherapy group (p<0.05). CONCLUSION: It was shown in this experimental model that melatonin has protective effects against radiation injury to kidneys.


Subject(s)
Antioxidants/therapeutic use , Gamma Rays/adverse effects , Melatonin/therapeutic use , Nephrosclerosis/prevention & control , Radiation Injuries/prevention & control , Radiation-Protective Agents/therapeutic use , Renal Insufficiency/prevention & control , Animals , Male , Nephrosclerosis/etiology , Radiation Injuries/etiology , Rats , Rats, Sprague-Dawley , Renal Insufficiency/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...